146 related articles for article (PubMed ID: 36587872)
21. [(3)H]-F13640, a novel, selective and high-efficacy serotonin 5-HT(1A) receptor agonist radioligand.
Heusler P; Palmier C; Tardif S; Bernois S; Colpaert FC; Cussac D
Naunyn Schmiedebergs Arch Pharmacol; 2010 Oct; 382(4):321-30. PubMed ID: 20799027
[TBL] [Abstract][Full Text] [Related]
22. Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist.
Meirsman AC; Le Merrer J; Pellissier LP; Diaz J; Clesse D; Kieffer BL; Becker JA
Biol Psychiatry; 2016 Jun; 79(11):917-27. PubMed ID: 26188600
[TBL] [Abstract][Full Text] [Related]
23. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
24. Tritium-labeled agonists as tools for studying adenosine A
Hinz S; Alnouri WM; Pleiss U; Müller CE
Purinergic Signal; 2018 Sep; 14(3):223-233. PubMed ID: 29752618
[TBL] [Abstract][Full Text] [Related]
25. Activation and allosteric regulation of the orphan GPR88-Gi1 signaling complex.
Chen G; Xu J; Inoue A; Schmidt MF; Bai C; Lu Q; Gmeiner P; Liu Z; Du Y
Nat Commun; 2022 May; 13(1):2375. PubMed ID: 35501348
[TBL] [Abstract][Full Text] [Related]
26. [3H]HEMADO--a novel tritiated agonist selective for the human adenosine A3 receptor.
Klotz KN; Falgner N; Kachler S; Lambertucci C; Vittori S; Volpini R; Cristalli G
Eur J Pharmacol; 2007 Feb; 556(1-3):14-8. PubMed ID: 17126322
[TBL] [Abstract][Full Text] [Related]
27. The orphan receptor GPR88 blunts the signaling of opioid receptors and multiple striatal GPCRs.
Laboute T; Gandía J; Pellissier LP; Corde Y; Rebeillard F; Gallo M; Gauthier C; Léauté A; Diaz J; Poupon A; Kieffer BL; Le Merrer J; Becker JA
Elife; 2020 Jan; 9():. PubMed ID: 32003745
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
[TBL] [Abstract][Full Text] [Related]
29. The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders.
Bi Y; Dzierba CD; Fink C; Garcia Y; Green M; Han J; Kwon S; Kumi G; Liang Z; Liu Y; Qiao Y; Zhang Y; Zipp G; Burford N; Ferrante M; Bertekap R; Lewis M; Cacace A; Westphal RS; Kimball D; Bronson JJ; Macor JE
Bioorg Med Chem Lett; 2015 Apr; 25(7):1443-7. PubMed ID: 25754495
[TBL] [Abstract][Full Text] [Related]
30. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and pharmacological characterization of a novel, highly potent, peptidomimetic delta-opioid radioantagonist, [3H]Tyr-Tic-(2S,3R)-beta-MePhe-Phe-OH.
Birkas E; Kertesz I; Toth G; Bakota L; Gulya K; Szucs M
Neuropeptides; 2008 Feb; 42(1):57-67. PubMed ID: 18068762
[TBL] [Abstract][Full Text] [Related]
32. Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents.
Massart R; Guilloux JP; Mignon V; Sokoloff P; Diaz J
Eur J Neurosci; 2009 Aug; 30(3):397-414. PubMed ID: 19656174
[TBL] [Abstract][Full Text] [Related]
33. Characterisation of human recombinant somatostatin receptors. 1. Radioligand binding studies.
Siehler S; Seuwen K; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):488-99. PubMed ID: 10598788
[TBL] [Abstract][Full Text] [Related]
34. The Orphan GPCR Receptor, GPR88, Interacts with Nuclear Protein Partners in the Cerebral Cortex.
Rebeillard F; De Gois S; Pietrancosta N; Mai TH; Lai-Kuen R; Kieffer BL; Giros B; Massart R; Darmon M; Diaz J
Cereb Cortex; 2022 Jan; 32(3):479-489. PubMed ID: 34247243
[TBL] [Abstract][Full Text] [Related]
35. The GPR88 receptor agonist 2-PCCA does not alter the behavioral effects of methamphetamine in rats.
Li JX; Thorn DA; Jin C
Eur J Pharmacol; 2013 Jan; 698(1-3):272-7. PubMed ID: 23123351
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA
J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
Khawaja X; Ennis C; Minchin MC
Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
[TBL] [Abstract][Full Text] [Related]
38. The orphan receptor GPR88 controls impulsivity and is a risk factor for Attention-Deficit/Hyperactivity Disorder.
Ben Hamida S; Sengupta SM; Clarke E; McNicholas M; Moroncini E; Darcq E; Ter-Stepanian M; Fortier MÈ; Grizenko N; Joober R; Kieffer BL
Mol Psychiatry; 2022 Nov; 27(11):4662-4672. PubMed ID: 36075963
[TBL] [Abstract][Full Text] [Related]
39. Design and pharmacological profile of a novel covalent partial agonist for the adenosine A
Yang X; Dilweg MA; Osemwengie D; Burggraaff L; van der Es D; Heitman LH; IJzerman AP
Biochem Pharmacol; 2020 Oct; 180():114144. PubMed ID: 32653590
[TBL] [Abstract][Full Text] [Related]
40. A radioreceptor binding assay for platelet-activating factor (PAF) using membranes from CHO cells expressing human PAF receptor.
Aoki Y; Nakamura M; Kodama H; Matsumoto T; Shimizu T; Noma M
J Immunol Methods; 1995 Oct; 186(2):225-31. PubMed ID: 7594622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
